BIOS.BR
Price:
$0.0023
Market Cap:
$1.50M
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.
Industry
Biotechnology
IPO Date
2015-02-03
Stock Exchange
BRU
Ticker
BIOS.BR
According to BioSenic S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 29.55M. This represents a change of -13.28% compared to the average of 34.07M of the last 4 quarters.
The mean historical Enterprise Value of BioSenic S.A. over the last ten years is 46.05M. The current 29.55M Enterprise Value has changed 6.32% with respect to the historical average. Over the past ten years (40 quarters), BIOS.BR's Enterprise Value was at its highest in in the June 2015 quarter at 111.55M. The Enterprise Value was at its lowest in in the December 2011 quarter at -2317000.00.
Average
46.05M
Median
39.39M
Minimum
8.21M
Maximum
107.45M
Discovering the peaks and valleys of BioSenic S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 307.86%
Maximum Annual Enterprise Value = 107.45M
Minimum Annual Increase = -73.20%
Minimum Annual Enterprise Value = 8.21M
| Year | Enterprise Value | Change |
|---|---|---|
| 2023 | 36.43M | 8.82% |
| 2022 | 33.48M | 307.86% |
| 2021 | 8.21M | -73.20% |
| 2020 | 30.63M | -23.14% |
| 2019 | 39.85M | 2.37% |
| 2018 | 38.93M | -33.49% |
| 2017 | 58.53M | 28.83% |
| 2016 | 45.43M | -57.72% |
| 2015 | 107.45M | 74.61% |
| 2014 | 61.54M | 18.56% |
The current Enterprise Value of BioSenic S.A. (BIOS.BR) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
26.04M
5-year avg
29.72M
10-year avg
46.05M
BioSenic S.A.’s Enterprise Value is greater than Celyad Oncology S.A. (8.32M), greater than GeNeuro S.A. (12.88M), greater than Oxurion N.V. (11.40M), less than Vivoryon Therapeutics N.V. (37.20M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 8.32M | $8.28M | |
| 12.88M | $1.34M | |
| 11.40M | $575.90K | |
| 37.20M | $41.97M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioSenic S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioSenic S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is BioSenic S.A.'s Enterprise Value?
What is the highest Enterprise Value for BioSenic S.A. (BIOS.BR)?
What is the 3-year average Enterprise Value for BioSenic S.A. (BIOS.BR)?
What is the 5-year average Enterprise Value for BioSenic S.A. (BIOS.BR)?
How does the current Enterprise Value for BioSenic S.A. (BIOS.BR) compare to its historical average?